(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are SmileDirectClub, Berkshire Hathaway, and TherapeuticsMD.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 SmileDirectClub (SDC) 2.21 11.06% 2022-01-25 04:17:38
2 Berkshire Hathaway (BRK-A) 483675.00 5.86% 2022-01-25 04:39:15
3 TherapeuticsMD (TXMD) 0.32 3.93% 2022-01-25 07:32:30
4 VerifyMe (VRME) 3.05 3.39% 2022-01-25 04:37:40
5 International Business Machines (IBM) 132.20 2.62% 2022-01-25 04:22:08
6 HomeAway (AWAY) 23.11 1.81% 2022-01-25 04:08:09
7 United Microelectronics (UMC) 11.08 1.56% 2022-01-25 04:47:28
8 BlackRock Science and Technology Trust (BST) 42.99 1.49% 2022-01-25 04:19:46
9 Canon (CAJ) 24.70 1.48% 2022-01-25 04:19:51
10 Bank Of Montreal (BMO) 113.98 1.39% 2022-01-25 04:39:09

The three most active and biggest losers today are FibroGen, Sherwin, and 10x Genomics.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 FibroGen (FGEN) 13.20 -8.14% 2022-01-25 04:11:02
2 Sherwin (SHW) 285.00 -4.53% 2022-01-25 04:46:08
3 10x Genomics (TXG) 90.57 -4.32% 2022-01-25 04:18:05
4 MSCI (MSCI) 486.03 -4.15% 2022-01-25 04:43:54
5 Check Point (CHKP) 119.50 -3.82% 2022-01-25 04:09:43
6 Discovery Inc (DISCA) 25.90 -3.65% 2022-01-25 04:10:21
7 Deere & Company (DE) 352.02 -3.3% 2022-01-25 04:20:36
8 Novavax (NVAX) 76.88 -3.26% 2022-01-25 04:13:16
9 MongoDB (MDB) 375.00 -2.96% 2022-01-25 04:16:55
10 Caesars Entertainment (CZR) 73.78 -2.87% 2022-01-25 04:10:19

Most Active Premarket Winners today

1. SmileDirectClub (SDC) – Premarket: 11.06%

NASDAQ ended the session with SmileDirectClub jumping 2.05% to $1.99 on Tuesday while NASDAQ rose 0.63% to $13,855.13.

Volume

Today’s last reported volume for SmileDirectClub is 8534950, 11.39% below its average volume of 9632830.

SmileDirectClub’s last close was $1.99, 87.62% below its 52-week high of $16.08.

SmileDirectClub’s Sales

SmileDirectClub’s sales growth is 25.6% for the ongoing quarter and 10% for the next. The company’s growth estimates for the present quarter and the next is a negative 18.2% and a negative 33.3%, respectively.

SmileDirectClub’s Revenue

Year-on-year quarterly revenue growth grew by 62.7%, now sitting on 726.7M for the twelve trailing months.

Volatility

SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.74%, a negative 1.26%, and a positive 5.55%, respectively.

SmileDirectClub’s highest amplitude of average volatility was 3.88% (last week), 6.49% (last month), and 5.55% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SmileDirectClub’s stock is considered to be overbought (>=80).

SmileDirectClub’s Stock Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $1.99 at 07:34 EST, way below its 52-week low of $2.54.

SmileDirectClub’s Moving Average

SmileDirectClub’s worth is way under its 50-day moving average of $4.62 and way under its 200-day moving average of $7.31.

Previous days news about SmileDirectClub

  • Why smiledirectclub stock is trading higher. According to Benzinga on Monday, 24 January, "Shares of SmileDirectClub Inc. (NASDAQ: SDC) spiked higher after hours following the announcement of a series of strategic actions to improve business performance, future growth, and cost structure to better support growth initiatives.", "At the time of publication, shares of SmileDirectClub were trading 13.1% higher post-market close at $2.25. "

More news about SmileDirectClub.

2. Berkshire Hathaway (BRK-A) – Premarket: 5.86%

NYSE ended the session with Berkshire Hathaway dropping 0.39% to $456,901.00 on Tuesday while NYSE dropped 1.6% to $16,397.34.

Volume

Today’s last reported volume for Berkshire Hathaway is 3706, 20488.9% above its average volume of 18.

Berkshire Hathaway’s last close was $456,901.00, 2.67% above its 52-week high of $445,000.00.

Berkshire Hathaway’s Sales

Berkshire Hathaway’s sales growth is a negative 23.4% for the present quarter and a decline by 30.6% for the next. The company’s growth estimates for the current quarter and the next is 42.3% and 32.9%, respectively.

Berkshire Hathaway’s Revenue

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 261.12B for the twelve trailing months.

Volatility

Berkshire Hathaway’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.25%, a positive 0.15%, and a positive 0.95%, respectively.

Berkshire Hathaway’s highest amplitude of average volatility was 1.25% (last week), 0.80% (last month), and 0.95% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Berkshire Hathaway’s stock is considered to be overbought (>=80).

Berkshire Hathaway’s Stock Yearly Top and Bottom Value

Berkshire Hathaway’s stock is valued at $456,901.00 at 07:34 EST, above its 52-week high of $445,000.00.

Berkshire Hathaway’s Moving Average

Berkshire Hathaway’s worth is above its 50-day moving average of $426,205.00 and higher than its 200-day moving average of $425,195.00.

More news about Berkshire Hathaway.

3. TherapeuticsMD (TXMD) – Premarket: 3.93%

NASDAQ ended the session with TherapeuticsMD sliding 2.71% to $0.31 on Tuesday while NASDAQ jumped 0.63% to $13,855.13.

Volume

Today’s last reported volume for TherapeuticsMD is 12989700, 111.21% above its average volume of 6149880.

TherapeuticsMD’s last close was $0.31, 88.91% under its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Volatility

TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.65%, a negative 1.37%, and a positive 5.84%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 4.33% (last week), 4.91% (last month), and 5.84% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.31 at 07:34 EST, way under its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s value is way under its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.

More news about TherapeuticsMD.

4. VerifyMe (VRME) – Premarket: 3.39%

NASDAQ ended the session with VerifyMe falling 3.28% to $2.95 on Tuesday, after five successive sessions in a row of losses. NASDAQ jumped 0.63% to $13,855.13, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for VerifyMe is 18435, 62.18% below its average volume of 48748.

VerifyMe’s last close was $2.95, 53.91% under its 52-week high of $6.40.

VerifyMe’s Sales

VerifyMe’s sales growth is 98% for the ongoing quarter and 300% for the next.

VerifyMe’s Revenue

Year-on-year quarterly revenue growth grew by 65.3%, now sitting on 488k for the twelve trailing months.

Volatility

VerifyMe’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.76%, a positive 0.17%, and a positive 3.37%, respectively.

VerifyMe’s highest amplitude of average volatility was 2.76% (last week), 3.53% (last month), and 3.37% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

VerifyMe’s stock is considered to be overbought (>=80).

VerifyMe’s Stock Yearly Top and Bottom Value

VerifyMe’s stock is valued at $2.95 at 07:34 EST, way below its 52-week high of $6.40 and higher than its 52-week low of $2.76.

VerifyMe’s Moving Average

VerifyMe’s value is way below its 50-day moving average of $3.47 and way under its 200-day moving average of $3.66.

More news about VerifyMe.

5. International Business Machines (IBM) – Premarket: 2.62%

NYSE ended the session with International Business Machines sliding 0.41% to $128.82 on Tuesday while NYSE fell 1.6% to $16,397.34.

Volume

Today’s last reported volume for International Business Machines is 11721300, 102.69% above its average volume of 5782860.

International Business Machines’s last close was $128.82, 15.72% under its 52-week high of $152.84.

The company’s growth estimates for the present quarter is a negative 3.1% and positive 102.4% for the next.

International Business Machines’s Revenue

Year-on-year quarterly revenue growth grew by 3.4%, now sitting on 74.4B for the twelve trailing months.

Volatility

International Business Machines’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.93%, a positive 0.06%, and a positive 0.84%, respectively.

International Business Machines’s highest amplitude of average volatility was 0.93% (last week), 0.82% (last month), and 0.84% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

International Business Machines’s stock is considered to be overbought (>=80).

International Business Machines’s Stock Yearly Top and Bottom Value

International Business Machines’s stock is valued at $128.82 at 07:34 EST, way under its 52-week high of $152.84 and way higher than its 52-week low of $114.56.

International Business Machines’s Moving Average

International Business Machines’s worth is above its 50-day moving average of $125.88 and below its 200-day moving average of $136.48.

More news about International Business Machines.

6. HomeAway (AWAY) – Premarket: 1.81%

NASDAQ ended the session with HomeAway dropping 1.9% to $22.70 on Tuesday while NASDAQ rose 0.63% to $13,855.13.

Volume

Today’s last reported volume for HomeAway is 309445, 3.46% below its average volume of 320540.

Volatility

HomeAway’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.65%, a negative 0.14%, and a positive 1.98%, respectively.

HomeAway’s highest amplitude of average volatility was 1.45% (last week), 1.40% (last month), and 1.98% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

HomeAway’s stock is considered to be overbought (>=80).

More news about HomeAway.

7. United Microelectronics (UMC) – Premarket: 1.56%

NYSE ended the session with United Microelectronics rising 0.28% to $10.91 on Tuesday, after two successive sessions in a row of gains. NYSE dropped 1.6% to $16,397.34, following the last session’s upward trend on what was an all-around down trend trading session today.

Volume

Today’s last reported volume for United Microelectronics is 19218700, 143.67% above its average volume of 7887110.

United Microelectronics’s last close was $10.91, 13.55% under its 52-week high of $12.62.

United Microelectronics’s Revenue

Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 188.17B for the twelve trailing months.

Volatility

United Microelectronics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.39%, a negative 0.18%, and a positive 2.27%, respectively.

United Microelectronics’s highest amplitude of average volatility was 1.39% (last week), 1.53% (last month), and 2.27% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

United Microelectronics’s stock is considered to be overbought (>=80).

United Microelectronics’s Stock Yearly Top and Bottom Value

United Microelectronics’s stock is valued at $10.91 at 07:34 EST, way below its 52-week high of $12.62 and way above its 52-week low of $5.43.

United Microelectronics’s Moving Average

United Microelectronics’s value is above its 50-day moving average of $10.84 and above its 200-day moving average of $10.25.

More news about United Microelectronics.

8. BlackRock Science and Technology Trust (BST) – Premarket: 1.49%

NYSE ended the session with BlackRock Science and Technology Trust dropping 0% to $42.36 on Tuesday, after five consecutive sessions in a row of losses. NYSE fell 1.6% to $16,397.34, following the last session’s upward trend on what was an all-around down trend trading session today.

Volume

Today’s last reported volume for BlackRock Science and Technology Trust is 530859, 188.39% above its average volume of 184074.

BlackRock Science and Technology Trust’s last close was $42.36, 31.85% below its 52-week high of $62.16.

Volatility

BlackRock Science and Technology Trust’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.52%, a negative 0.55%, and a positive 1.29%, respectively.

BlackRock Science and Technology Trust’s highest amplitude of average volatility was 2.52% (last week), 1.49% (last month), and 1.29% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BlackRock Science and Technology Trust’s stock is considered to be overbought (>=80).

BlackRock Science and Technology Trust’s Stock Yearly Top and Bottom Value

BlackRock Science and Technology Trust’s stock is valued at $42.36 at 07:34 EST, way below its 52-week low of $49.04.

BlackRock Science and Technology Trust’s Moving Average

BlackRock Science and Technology Trust’s worth is way under its 50-day moving average of $53.31 and way below its 200-day moving average of $54.92.

More news about BlackRock Science and Technology Trust.

9. Canon (CAJ) – Premarket: 1.48%

NYSE ended the session with Canon rising 1.88% to $24.34 on Tuesday while NYSE fell 1.6% to $16,397.34.

Volume

Today’s last reported volume for Canon is 476528, 25.51% above its average volume of 379648.

Canon’s last close was $24.34, 6.17% below its 52-week high of $25.94.

Canon’s Sales

Canon’s sales growth is 18.3% for the ongoing quarter and a decline by 1.4% for the next. The company’s growth estimates for the current quarter and the next is 157.1% and 4.1%, respectively.

Canon’s Revenue

Year-on-year quarterly revenue growth grew by 31%, now sitting on 3.43T for the twelve trailing months.

Volatility

Canon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a negative 0.31%, and a positive 0.94%, respectively.

Canon’s highest amplitude of average volatility was 0.52% (last week), 0.65% (last month), and 0.94% (last quarter), respectively.

Canon’s Stock Yearly Top and Bottom Value

Canon’s stock is valued at $24.34 at 07:34 EST, below its 52-week high of $25.94 and way higher than its 52-week low of $18.17.

Canon’s Moving Average

Canon’s worth is above its 50-day moving average of $23.24 and higher than its 200-day moving average of $23.39.

More news about Canon.

10. Bank Of Montreal (BMO) – Premarket: 1.39%

NYSE ended the session with Bank Of Montreal falling 1.39% to $112.42 on Tuesday, after four consecutive sessions in a row of losses. NYSE dropped 1.6% to $16,397.34, following the last session’s upward trend on what was an all-around down trend trading session today.

Volume

Today’s last reported volume for Bank Of Montreal is 1153170, 69.58% above its average volume of 679977.

Bank Of Montreal’s last close was $112.42, 0.05% under its 52-week high of $112.48.

Bank Of Montreal’s Sales

Bank Of Montreal’s sales growth is a negative 6.7% for the present quarter and a decline by 0.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 10.6% and 8.7%, respectively.

Bank Of Montreal’s Revenue

Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 25.94B for the twelve trailing months.

Volatility

Bank Of Montreal’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.33%, a positive 0.42%, and a positive 0.96%, respectively.

Bank Of Montreal’s highest amplitude of average volatility was 1.33% (last week), 1.02% (last month), and 0.96% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bank Of Montreal’s stock is considered to be overbought (>=80).

Bank Of Montreal’s Stock Yearly Top and Bottom Value

Bank Of Montreal’s stock is valued at $112.42 at 07:34 EST, below its 52-week high of $112.48 and way above its 52-week low of $65.65.

Bank Of Montreal’s Moving Average

Bank Of Montreal’s value is higher than its 50-day moving average of $106.34 and above its 200-day moving average of $102.33.

More news about Bank Of Montreal.

Most Active Premarket Losers Today

1. FibroGen (FGEN) – Premarket: -8.14%

NASDAQ ended the session with FibroGen rising 3.98% to $14.37 on Tuesday, after three sequential sessions in a row of gains. NASDAQ jumped 0.63% to $13,855.13, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for FibroGen is 1335480, 11.69% above its average volume of 1195630.

FibroGen’s last close was $14.37, 74.88% under its 52-week high of $57.21.

FibroGen’s Sales

FibroGen’s sales growth is 201.9% for the present quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 1.70%, 0.58%, and 2.75%, respectively.

FibroGen’s highest amplitude of average volatility was 1.85% (last week), 2.78% (last month), and 2.75% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be oversold (<=20).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $14.37 at 07:34 EST, way under its 52-week high of $57.21 and way above its 52-week low of $9.88.

FibroGen’s Moving Average

FibroGen’s value is way higher than its 50-day moving average of $11.90 and way under its 200-day moving average of $18.77.

More news about FibroGen.

2. Sherwin (SHW) – Premarket: -4.53%

NYSE ended the session with Sherwin jumping 1.94% to $298.52 on Tuesday while NYSE dropped 1.6% to $16,397.34.

Volume

Today’s last reported volume for Sherwin is 2884130, 134.14% above its average volume of 1231790.

Sherwin’s last close was $298.52, 8.35% under its 52-week high of $325.73.

Sherwin’s Sales

Sherwin’s sales growth is 3.3% for the current quarter and 9.2% for the next. The company’s growth estimates for the current quarter is a negative 9.1% and positive 18.2% for the next.

Sherwin’s Revenue

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 19.65B for the twelve trailing months.

Volatility

Sherwin’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.50%, a negative 0.60%, and a positive 0.92%, respectively.

Sherwin’s highest amplitude of average volatility was 1.50% (last week), 1.28% (last month), and 0.92% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sherwin’s stock is considered to be overbought (>=80).

Sherwin’s Stock Yearly Top and Bottom Value

Sherwin’s stock is valued at $298.52 at 07:34 EST, under its 52-week high of $325.73 and way higher than its 52-week low of $218.06.

Sherwin’s Moving Average

Sherwin’s worth is below its 50-day moving average of $301.15 and higher than its 200-day moving average of $290.42.

More news about Sherwin.

3. 10x Genomics (TXG) – Premarket: -4.32%

NASDAQ ended the session with 10x Genomics jumping 6.01% to $94.66 on Tuesday, after two sequential sessions in a row of gains. NASDAQ rose 0.63% to $13,855.13, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for 10x Genomics is 1643600, 100.57% above its average volume of 819441.

10x Genomics’s last close was $94.66, 54.71% under its 52-week high of $208.99.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the current quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.

Volatility

10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.23%, a negative 2.46%, and a positive 3.33%, respectively.

10x Genomics’s highest amplitude of average volatility was 4.11% (last week), 3.56% (last month), and 3.33% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $94.66 at 07:34 EST, way under its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s value is way below its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.

More news about 10x Genomics.

4. MSCI (MSCI) – Premarket: -4.15%

NYSE ended the session with MSCI jumping 1.25% to $507.07 on Tuesday while NYSE fell 1.6% to $16,397.34.

Volume

Today’s last reported volume for MSCI is 838747, 125.75% above its average volume of 371538.

MSCI’s last close was $507.07, 24.29% under its 52-week high of $669.72.

MSCI’s Sales

MSCI’s sales growth is 19.6% for the present quarter and 17.5% for the next. The company’s growth estimates for the present quarter and the next is 9.1% and 27%, respectively.

MSCI’s Revenue

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 1.85B for the twelve trailing months.

Volatility

MSCI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.95%, a negative 1.17%, and a positive 1.86%, respectively.

MSCI’s highest amplitude of average volatility was 1.19% (last week), 1.63% (last month), and 1.86% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MSCI’s stock is considered to be overbought (>=80).

MSCI’s Stock Yearly Top and Bottom Value

MSCI’s stock is valued at $507.07 at 07:34 EST, way below its 52-week high of $669.72 and way higher than its 52-week low of $380.00.

MSCI’s Moving Average

MSCI’s worth is way below its 50-day moving average of $629.90 and way under its 200-day moving average of $571.97.

More news about MSCI.

5. Check Point (CHKP) – Premarket: -3.82%

NASDAQ ended the session with Check Point dropping 0.66% to $124.24 on Tuesday, following the last session’s downward trend. NASDAQ jumped 0.63% to $13,855.13, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Check Point is 1415030, 16.4% above its average volume of 1215620.

Check Point’s last close was $124.24, 10.79% below its 52-week high of $139.26.

Check Point’s Sales

Check Point’s sales growth is 3.9% for the ongoing quarter and 4% for the next. The company’s growth estimates for the present quarter is a negative 1.4% and positive 5.2% for the next.

Check Point’s Revenue

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 2.13B for the twelve trailing months.

Volatility

Check Point’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.24%, a positive 0.39%, and a positive 1.01%, respectively.

Check Point’s highest amplitude of average volatility was 0.40% (last week), 1.11% (last month), and 1.01% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Check Point’s stock is considered to be overbought (>=80).

Check Point’s Stock Yearly Top and Bottom Value

Check Point’s stock is valued at $124.24 at 07:34 EST, way under its 52-week high of $139.26 and way above its 52-week low of $107.85.

Check Point’s Moving Average

Check Point’s value is above its 50-day moving average of $116.16 and higher than its 200-day moving average of $118.49.

More news about Check Point.

6. Discovery Inc (DISCA) – Premarket: -3.65%

NASDAQ ended the session with Discovery Inc jumping 2.63% to $26.88 on Tuesday, following the last session’s upward trend. NASDAQ jumped 0.63% to $13,855.13, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Discovery Inc is 8508200, 10.68% above its average volume of 7686680.

Discovery Inc’s last close was $26.88, 65.6% below its 52-week high of $78.14.

Discovery Inc’s Sales

Discovery Inc’s sales growth is 26.7% for the present quarter and 10.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 51.9% and positive 14.5% for the next.

Discovery Inc’s Revenue

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 10.78B for the twelve trailing months.

Volatility

Discovery Inc’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.50%, a positive 1.02%, and a positive 2.61%, respectively.

Discovery Inc’s highest amplitude of average volatility was 3.82% (last week), 3.91% (last month), and 2.61% (last quarter), respectively.

Discovery Inc’s Stock Yearly Top and Bottom Value

Discovery Inc’s stock is valued at $26.88 at 07:34 EST, way under its 52-week high of $78.14 and way higher than its 52-week low of $22.20.

Discovery Inc’s Moving Average

Discovery Inc’s worth is above its 50-day moving average of $25.28 and way below its 200-day moving average of $33.50.

More news about Discovery Inc.

7. Deere & Company (DE) – Premarket: -3.3%

NYSE ended the session with Deere & Company falling 0.07% to $364.03 on Tuesday while NYSE fell 1.6% to $16,397.34.

Volume

Today’s last reported volume for Deere & Company is 2057570, 18.03% above its average volume of 1743210.

Deere & Company’s last close was $364.03, 9.07% under its 52-week high of $400.34.

The company’s growth estimates for the current quarter and the next is 71.1% and 15.2%, respectively.

Deere & Company’s Revenue

Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 42.4B for the twelve trailing months.

Volatility

Deere & Company’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.77%, a positive 0.14%, and a positive 1.44%, respectively.

Deere & Company’s highest amplitude of average volatility was 1.77% (last week), 1.24% (last month), and 1.44% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Deere & Company’s stock is considered to be overbought (>=80).

Deere & Company’s Stock Yearly Top and Bottom Value

Deere & Company’s stock is valued at $364.03 at 07:34 EST, below its 52-week high of $400.34 and way higher than its 52-week low of $252.51.

Deere & Company’s Moving Average

Deere & Company’s value is higher than its 50-day moving average of $348.74 and higher than its 200-day moving average of $359.69.

More news about Deere & Company.

8. Novavax (NVAX) – Premarket: -3.26%

NASDAQ ended the session with Novavax dropping 6.12% to $79.47 on Tuesday while NASDAQ rose 0.63% to $13,855.13.

Volume

Today’s last reported volume for Novavax is 12876500, 114.92% above its average volume of 5991160.

Novavax’s last close was $79.47, 76.04% below its 52-week high of $331.68.

The company’s growth estimates for the current quarter is a negative 21.8% and positive 213.7% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.2B for the twelve trailing months.

Volatility

Novavax’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.52%, a negative 3.14%, and a positive 5.15%, respectively.

Novavax’s highest amplitude of average volatility was 5.52% (last week), 4.26% (last month), and 5.15% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be overbought (>=80).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $79.47 at 07:34 EST, way below its 52-week low of $107.08.

Novavax’s Moving Average

Novavax’s value is way below its 50-day moving average of $170.98 and way under its 200-day moving average of $193.54.

More news about Novavax.

9. MongoDB (MDB) – Premarket: -2.96%

NASDAQ ended the session with MongoDB jumping 2.9% to $386.45 on Tuesday while NASDAQ rose 0.63% to $13,855.13.

Volume

Today’s last reported volume for MongoDB is 1944470, 101.34% above its average volume of 965748.

MongoDB’s last close was $386.45, 34.5% under its 52-week high of $590.00.

The company’s growth estimates for the current quarter and the next is a negative 19.4% and a negative 3%, respectively.

MongoDB’s Revenue

Year-on-year quarterly revenue growth grew by 43.7%, now sitting on 702.16M for the twelve trailing months.

Volatility

MongoDB’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.19%, a negative 2.81%, and a positive 3.87%, respectively.

MongoDB’s highest amplitude of average volatility was 1.82% (last week), 3.62% (last month), and 3.87% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MongoDB’s stock is considered to be oversold (<=20).

MongoDB’s Stock Yearly Top and Bottom Value

MongoDB’s stock is valued at $386.45 at 07:34 EST, way under its 52-week high of $590.00 and way higher than its 52-week low of $238.01.

MongoDB’s Moving Average

MongoDB’s value is way below its 50-day moving average of $509.44 and below its 200-day moving average of $389.11.

More news about MongoDB.

10. Caesars Entertainment (CZR) – Premarket: -2.87%

NASDAQ ended the session with Caesars Entertainment jumping 5.25% to $75.96 on Tuesday while NASDAQ rose 0.63% to $13,855.13.

Volume

Today’s last reported volume for Caesars Entertainment is 5534760, 119.54% above its average volume of 2521030.

Caesars Entertainment’s last close was $75.96, 36.6% under its 52-week high of $119.81.

The company’s growth estimates for the present quarter and the next is 102.5% and 101.1%, respectively.

Caesars Entertainment’s Revenue

Year-on-year quarterly revenue growth grew by 1870.1%, now sitting on 7.16B for the twelve trailing months.

Volatility

Caesars Entertainment’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.06%, a negative 0.72%, and a positive 2.70%, respectively.

Caesars Entertainment’s highest amplitude of average volatility was 3.68% (last week), 2.07% (last month), and 2.70% (last quarter), respectively.

Caesars Entertainment’s Stock Yearly Top and Bottom Value

Caesars Entertainment’s stock is valued at $75.96 at 07:34 EST, way under its 52-week high of $119.81 and way above its 52-week low of $66.34.

Caesars Entertainment’s Moving Average

Caesars Entertainment’s worth is way under its 50-day moving average of $104.43 and way under its 200-day moving average of $99.72.

More news about Caesars Entertainment.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here